Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
OPERATING ACTIVITIES:
Net income (loss)	$ 498	$ (207,056)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	6,447	4,781
Amortization of debt issuance costs	1,576	3,331
Provision for doubtful accounts	1,999	1,007
Equity-based compensation expense	2,221	1,813
Windfall tax benefits associated with equity-based compensation	(6)	(72)
Goodwill and other long-lived asset impairment	0	224,320	[1]
Deferred income tax expense (benefit)	4,301	(9,360)
Changes in assets and liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	(3,432)	(4,855)
Prepaid expenses and other current assets	(1,922)	(162)
Accounts payable	(3,063)	(193)
Payroll and related taxes	(14,636)	(10,977)
Deferred revenue	5,038	2,376
Medicare liabilities	(1,762)	210
Obligations under insurance programs	(3,558)	(1,991)
Accrued nursing home costs	(1,250)	602
Other accrued expenses	(9,121)	(25,285)
Other, net	(1,073)	951
Net cash used in operating activities	(17,743)	(20,560)
INVESTING ACTIVITIES:
Purchase of fixed assets	(3,158)	(2,698)
Proceeds from the sale of assets	191	0
Net cash used in investing activities	(2,967)	(2,698)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock	597	992
Windfall tax benefits associated with equity-based compensation	6	72
Repayment of long-term debt	(4,581)	(25,000)
Minority interest capital contributions	1,160	0
Distribution to minority interests	(115)	(240)
Other	(430)	(23)
Net cash used in financing activities	(3,363)	(24,199)
Net change in cash and cash equivalents	(24,073)	(47,457)
Cash and cash equivalents at beginning of period	86,957	207,052
Cash and cash equivalents at end of period	62,884	159,595
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	33,047	28,728
Income taxes paid	$ 108	$ 194

[1] (2)At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit. Based on the results of the interim impairment test, the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million. See Note 9.In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million.Hospice and corporate assets were reduced by $220.8 million and $3.5 million , respectively, as a result of the impairment.